Presented below are condensed financial statements adapted from
those of two actual companies competing as the primary players in a
specialty area of the food manufacturing and distribution industry.
($ in millions, except per share amounts.)
Balance Sheets | |||||||
Metropolitan | Republic | ||||||
Assets | |||||||
Cash | $ | 289.3 | $ | 43.3 | |||
Accounts receivable (net) | 522.7 | 423.0 | |||||
Short-term investments | — | 8.5 | |||||
Inventory | 572.4 | 725.2 | |||||
Prepaid expenses and other current assets | 225.6 | 587.7 | |||||
Current assets | $ | 1,610.0 | $ | 1,787.7 | |||
Property, plant, and equipment (net) | 2,707.2 | 2,712.9 | |||||
Intangibles and other assets | 306.3 | 610.6 | |||||
Total assets | $ | 4,623.5 | $ | 5,111.2 | |||
Liabilities and Shareholders’ Equity | |||||||
Accounts payable | $ | 581.9 | $ | 794.2 | |||
Short-term notes | 323.1 | 652.4 | |||||
Accruals and other current liabilities | 694.2 | 628.5 | |||||
Current liabilities | $ | 1,599.2 | $ | 2,075.1 | |||
Long-term debt | 658.6 | 662.3 | |||||
Deferred tax liability | 482.6 | 712.7 | |||||
Other long-term liabilities | 223.0 | 205.1 | |||||
Total liabilities | $ | 2,963.4 | $ | 3,655.2 | |||
Common stock (par and additional paid-in capital) | 238.9 | 448.0 | |||||
Retained earnings | 2,574.9 | 1,702.9 | |||||
Less: Treasury stock | (1,153.7 | ) | (694.9 | ) | |||
Total liabilities and shareholders’ equity | $ | 4,623.5 | $ | 5,111.2 | |||
Income Statements | |||||||
Net sales | $ | 5,803.0 | $ | 7,866.2 | |||
Cost of goods sold | (2,811.0 | ) | (4,380.7 | ) | |||
Gross profit | $ | 2,992.0 | $ | 3,485.5 | |||
Operating expenses | (1,636.7 | ) | (2,924.2 | ) | |||
Interest expense | (88.8 | ) | (43.6 | ) | |||
Income before taxes | $ | 1,266.5 | $ | 517.7 | |||
Income tax expense | (288.7 | ) | (28.1 | ) | |||
Net income | $ | 977.8 | $ | 489.6 | |||
Net income per share | $ | 1.8 | $ | 7.8 | |||
Evaluate and compare the two companies by responding to the
following questions.
Note: Because comparative statements are not
provided you should use year-end balances in place of average
balances as appropriate.
Required:
1. For both companies, compute the ratios
below.
2. Evaluate and compare the two companies.
For both companies, compute the ratios below. (Consider 365 days a year. Do not round intermediate calculations and round your final answers to 2 decimal places.)
|
Evaluate and compare the two companies.
|
Presented below are condensed financial statements adapted from those of two actual companies competing as the...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 282.3 $ 43.1 Accounts receivable (net) 513.7 416.0 Short-term investments — 8.3 Inventories 562.4 719.2 Prepaid expenses and other current assets 216.6 576.7 Current assets $ 1,575.0 $ 1,763.3 Property, plant, and equipment (net) 2,702.2 2,656.5 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 282.3 $ 43.1 Accounts receivable (net) 513.7 416.0 Short-term investments — 8.3 Inventories 562.4 719.2 Prepaid expenses and other current assets 216.6 576.7 Current assets $ 1,575.0 $ 1,763.3 Property, plant, and equipment (net) 2,702.2 2,656.5 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 282.3 $ 43.1 Accounts receivable (net) 513.7 416.0 Short-term investments — 8.3 Inventories 562.4 719.2 Prepaid expenses and other current assets 216.6 576.7 Current assets $ 1,575.0 $ 1,763.3 Property, plant, and equipment (net) 2,702.2 2,656.5 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution Industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic $ 232.3 465.7 510.4 172.6 $ 1,381.6 2,656.2 256.3 $ 4,293.5 $ 42.8 365.6 7.4 673.2 533.7 $ 1,621.3 2,348.3 528.6 $ 4,498.1 Assets Cash Accounts receivable (net) Short-term investments Inventory Prepaid expenses and other current assets Current assets Property,...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution Industry ($ in millions, except per share amounts.) Balance Sheets Metropolitan $ 232.3 465.7 519.4 172.6 $ 1,381.6 2,656.2 256.3 $ 4,293.5 Republic $ 42.0 365. 7.4 673.2 533.7 $ 1,621.3 2,348.3 528.6 $ 4,498.1 Assets Cash Accounts receivable (net) Short-term investments Inventory Prepaid expenses and other current assets Current assets Property,...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 16,779 $ 11,244 Short-term investments 6,144 12,400 Accounts receivable (net) 8,894 11,095 Inventories 5,744 9,603 Other current assets 5,790 5,655 Current assets 43,351 49,997 Property, plant, and equipment (net) 15,542 23,983 Intangibles and other assets...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 10,641 $ 5,801 Short-term investments 5,037 11,293 Accounts receivable (net) 7,589 9,790 Inventories 4,520 7,459 Other current assets 4,395 4,260 Current assets 32,182 38,603 Property, plant, and equipment (net) 12,338 20,779 Intangibles and other assets...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry, Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 9,959 $ 5,184 Short-term investments 4,914 11,170 Accounts receivable (net) 7,444 9,645 Inventories 4,384 7,233 Other current assets 4,240 4,105 Current assets 30,941 37,337 Property, plant, and equipment (net) 11,982 20.423 Intangibles and other...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 18,143 $ 12,398 Short-term investments 6,390 12,646 Accounts receivable (net) 9,184 11,385 Inventories 6,016 10,135 Other current assets 6,100 5,965 Current assets 45,833 52,529 Property, plant, and equipment (net) 16,254 24,695 Intangibles and other assets...
The condensed financial statements of Ivanhoe Company for the years 2016 and 2017 are presented below. IVANHOE COMPANY Balance Sheets December 31 (in thousands) 2017 2016 Current assets Cash and cash equivalents $330 $360 Accounts receivable (net) 580 510 Inventory 550 480 Prepaid expenses 130 160 Total current assets 1,590 1,510 Property, plant, and equipment (net) 410 380 Investments 120 120 Intangibles and other assets 530 510 Total assets $2,650 $2,520 Current liabilities $930 $900 Long-term liabilities 570 470 Stockholders’...